Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2950-2956, June 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horiguchi, S.
Right arrow Articles by Kiessling, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horiguchi, S.
Right arrow Articles by Kiessling, R.
[Cancer Research 59, 2950-2956, June 15, 1999]
© 1999 American Association for Cancer Research


Immunology

Primary Chemically Induced Tumors Induce Profound Immunosuppression Concomitant with Apoptosis and Alterations in Signal Transduction in T Cells and NK Cells1

Shigetoshi Horiguchi2, Max Petersson2, Tsutomu Nakazawa2, Minoru Kanda, Arnold H. Zea, Augusto C. Ochoa and Rolf Kiessling3

Immune and Genetherapy Laboratory, Cancer Centrum Karolinska, Karolinska Institutet, S-171 76 Stockholm, Sweden [S. H., M. P., T. N., M. K., R. K.]; Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77 Stockholm, Sweden [S. H., M. P., T. N., M. K., R. K.]; and Louisiana State University Medical Center, Immunotherapy Program, Stanley S. Scott Cancer Center, New Orleans, Louisiana 70112 [A. H. Z., A. C. O.]

Whereas transplantable tumors can be readily cured with immunotherapeutic approaches, similar therapies in cancer patients have been less effective. This difference may be explained by an immunosuppression resulting from the presence of a slowly growing primary tumor in the patient, whereas the immune system in a mouse with a rapidly proliferating transplantable tumor would be less affected. As a more appropriate model to the immune dysfunction in patients, slowly progressing primary tumors were induced by the carcinogen methylcholanthrene (MC) in mice. Their ability to induce immunosuppression in T cells and natural killer (NK) cells was compared to that of rapidly growing transplanted MC-induced tumors. The results demonstrate that mice bearing primary MC tumors had significantly diminished T-cell and NK-cell functions, impaired capacity to produce Th1 cytokines, and markedly reduced levels of the signal-transducing {zeta} chain in T cells and NK cells, similar to that described in cancer patients. Moreover, a substantial number of CD8+ T cells in mice with large primary MC tumors were undergoing apoptosis, correlating with alterations in CD4/CD8 ratios. In contrast, T cells and NK cells from mice bearing rapidly growing transplanted tumors were only marginally affected. These findings could explain the apparent discrepancy between the consistent findings of a diminished immune response and alterations in signal transduction in cancer patients as compared to the less reproducible observations in murine transplantable tumors. In addition, they could explain the differences in the high efficacy of immunotherapy in mice with transplantable tumors and the low therapeutic results in cancer patients.




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
G. Willimsky, M. Czeh, C. Loddenkemper, J. Gellermann, K. Schmidt, P. Wust, H. Stein, and T. Blankenstein
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
J. Exp. Med., July 7, 2008; 205(7): 1687 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Takahashi, M. G. V. Hanson, H. R. Norell, A. M. Havelka, K. Kono, K.-J. Malmberg, and R. V. R. Kiessling
Preferential Cell Death of CD8+ Effector Memory (CCR7-CD45RA-) T Cells by Hydrogen Peroxide-Induced Oxidative Stress
J. Immunol., May 15, 2005; 174(10): 6080 - 6087.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Yokomura, T. Suda, S. Sasaki, N. Inui, K. Chida, and H. Nakamura
Increased Expression of the 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5704 - 5709.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii
Increased Populations of Regulatory T Cells in Peripheral Blood and Tumor-Infiltrating Lymphocytes in Patients with Gastric and Esophageal Cancers
Clin. Cancer Res., October 1, 2003; 9(12): 4404 - 4408.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K.-J. Malmberg, R. Lenkei, M. Petersson, T. Ohlum, F. Ichihara, B. Glimelius, J.-E. Frodin, G. Masucci, and R. Kiessling
A Short-Term Dietary Supplementation of High Doses of Vitamin E Increases T Helper 1 Cytokine Production in Patients with Advanced Colorectal Cancer
Clin. Cancer Res., June 1, 2002; 8(6): 1772 - 1778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Ali, J. Lynam, C. S. McLean, C. Entwisle, P. Loudon, J. M. Rojas, S. E. B. McArdle, G. Li, S. Mian, and R. C. Rees
Tumor Regression Induced by Intratumor Therapy with a Disabled Infectious Single Cycle (DISC) Herpes Simplex Virus (HSV) Vector, DISC/HSV/Murine Granulocyte-Macrophage Colony-Stimulating Factor, Correlates with Antigen-Specific Adaptive Immunity
J. Immunol., April 1, 2002; 168(7): 3512 - 3519.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-J. Malmberg, V. Arulampalam, F. Ichihara, M. Petersson, K. Seki, T. Andersson, R. Lenkei, G. Masucci, S. Pettersson, and R. Kiessling
Inhibition of Activated/Memory (CD45RO+) T Cells by Oxidative Stress Associated with Block of NF-{kappa}B Activation
J. Immunol., September 1, 2001; 167(5): 2595 - 2601.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Takagi, T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi, and T. Yokokura
Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism
Carcinogenesis, April 1, 2001; 22(4): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. M. Putzer, T. Stiewe, F. Rodicker, O. Schildgen, S. Ruhm, O. Dirsch, M. Fiedler, U. Damen, B. Tennant, C. Scherer, et al.
Large Nontransplanted Hepatocellular Carcinoma in Woodchucks: Treatment With Adenovirus-Mediated Delivery of Interleukin 12/B7.1 Genes
J Natl Cancer Inst, March 21, 2001; 93(6): 472 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Rovero, A. Amici, E. D. Carlo, R. Bei, P. Nanni, E. Quaglino, P. Porcedda, K. Boggio, A. Smorlesi, P.-L. Lollini, et al.
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice
J. Immunol., November 1, 2000; 165(9): 5133 - 5142.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. D. Santin, P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon
Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes
J. Virol., May 15, 2000; 74(10): 4729 - 4737.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. Forni, P. L. Lollini, P. Musiani, and M. P. Colombo
Immunoprevention of Cancer: Is the Time Ripe?
Cancer Res., May 1, 2000; 60(10): 2571 - 2575.
[Abstract] [Full Text]


Home page
BloodHome page
B. R. Gastman, D. E. Johnson, T. L. Whiteside, and H. Rabinowich
Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events
Blood, March 15, 2000; 95(6): 2015 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Willimsky and T. Blankenstein
Interleukin-7/B7.1-encoding Adenoviruses Induce Rejection of Transplanted but not Nontransplanted Tumors
Cancer Res., February 1, 2000; 60(3): 685 - 692.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.